3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Join Veristat and oncology drug developers at the Clinical Operations in Oncology Trials West Coast 2017 event. The event aims to explore innovative strategies in patient recruitment and retention, site engagement and vendor management for better cost efficiency and high data quality in oncology trials.
The agenda includes topics that Veristat is well versed in such as:
Meet up with Veristat while you are at this event! Veristat’s experienced teams have helped clients run over 335 Oncology studies for solid tumors, hematologic malignancies and more. Additionally, we’ve worked on over 20 US and European regulatory submission projects for cancer treatments, including many rare cancers.
Don’t forget to stop by our booth #3 to meet with our experts to talk about the challenges you are facing with your clinical trial design, execution and regulatory submission projects.
Fill out the form on the right to schedule a specific time to meet with Jessica Young or Kimberly Britt at the conference.
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...